STAT Plus: Boehringer to pay $379,000 to settle charges of wage discrimination against female employees
Following a review by the Department of Labor, a unit of Boehringer Ingelheim agreed to…
Category: Pharmaceuticals
STAT Plus: J&J to buy Momenta Pharma in a bid to bolster autoimmune disease pipeline
Health care giant Johnson & Johnson said Wednesday that it is acquiring Momenta Pharmaceuticals, gaining…
Trump campaign’s Facebook ad blitz casts Biden as pharma’s preferred candidate
WASHINGTON — President Trump’s reelection campaign is appealing to swing voters by attacking “Big Pharma”…
STAT Plus: A long-awaited report on orphan drugs in Europe suggests incentives to pharma need change
After being kept under wraps for a year, an expansive review of European regulations designed…
STAT Plus: Seizing on India’s lax standards for Covid-19 drugs, critics push for an overhaul on transparency
As Indian regulators endorse controversial treatments for Covid-19, a group of high-profile physicians and activists…
.jpg)
Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
WASHINGTON — The world’s biggest drug makers and their trade groups have cut checks to…
STAT Plus: Justice Department probes Sanofi and GlaxoSmithKline over possible carcinogen in Zantac pills
The Department of Justice has started investigating whether drug makers failed to disclose information about…
STAT Plus: Music in drug ads makes it easier for the public to tune out side effects, advocates argue
This will not be music to the ears of the pharmaceutical industry. A pair of…
FDA says opioid labels must include information about naloxone
WASHINGTON — The Food and Drug Administration announced Thursday that it would require drug manufacturers…
STAT Plus: The FDA got a lot more flexible during Covid — and pharma’s already pushing to make it permanent
WASHINGTON — The pharmaceutical industry made it clear to the Food and Drug Administration that…
STAT Plus: ‘Inactive’ drug ingredients are not always inactive, study finds
What’s in that pill you just swallowed? The label on the bottle lists the drug’s…
Opinion: The pandemic has exposed our broken pharma supply chain. Synthetic biology and brewer’s yeast could fix it
Covid-19 has depleted stockpiles of essential medicines in the U.S., straining our supply chains and…
STAT Plus: Venter Institute, Yumanity, and other biopharma companies among recipients of PPP loans
Yumanity, the J. Craig Venter Institute, and dozens of other companies around the biotech industry…
STAT Plus: Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges
And so, another working week will soon come to an end. Not a moment too…
STAT Plus: Pharmalittle: FDA sets Covid-19 vaccine guidance; White House grabs much of the remdesivir supply
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT+ Conversations: The state of the pharmaceutical industry, featuring Pharmalot’s Ed Silverman
Editor’s note: A livestream of this conversation will be embedded below at 1 p.m. ET. …
A new FDA tool aims to inform cancer care, but experts say it has a glaring gap
A new Food and Drug Administration platform gives cancer patients and physicians a way to…
STAT Plus: Pharmalittle: Pharma giants plan $1 billion antibiotic venture; Gilead prices remdesivir below most estimates
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Gilead announces long-awaited price for Covid-19 drug remdesivir
Since remdesivir became the first medicine shown to have an impact on Covid-19, doctors, politicians,…
STAT Plus: Pharma giants to unveil major $1 billion venture to push novel antibiotics
Amid escalating concerns over antibiotic resistance, several big drug makers are creating a new $1…
STAT Plus: Pfizer sues Trump administration over anti-kickback rules, saying they prevent it from helping lower seniors’ drug costs
WASHINGTON — Pharmaceutical giant Pfizer is suing the Trump administration over two long-standing Medicare rules…
STAT Plus: A pill to fight alcoholism causes an uproar in France over a regulator’s view of a clinical trial
Two years ago, French regulators made a surprising decision, overruling one of their own expert…
STAT Plus: After a bribery scandal in China, GSK found a suspected whistleblower. The real one is still waiting in the shadows
Alarmed that colleagues were bribing Chinese doctors and giving kickbacks to hospital workers to boost…
Opinion: An ‘America first’ pharma supply chain sounds good. But it won’t work
With a stroke of the president’s Executive Order pen, the Trump administration awarded a $354…
STAT Plus: Royalty Pharma, a drug company that doesn’t develop drugs, shatters IPO record
Royalty Pharma, a business built on investing in other people’s medicines, raised $2.2 billion in…
Opinion: Covid-19 and remdesivir: rethinking how we measure a drug’s ‘value’
As pharmaceutical and biotech companies scramble to identify treatments for Covid-19, a new disease that…
STAT Plus: Many Canadian medical societies fail to disclose industry funding in their clinical guidelines
Many Canadian medical societies and specially focused disease groups fail to disclose industry funding in…
STAT Plus: The next record-setting IPO: a drug company that doesn’t develop drugs
Royalty Pharma, a business built on investing in other people’s medicines, is planning to raise…
STAT Plus: Lawmakers, government watchdog blast FDA for poor oversight of U.S. drug supply chain
WASHINGTON — A government watchdog blasted the Food and Drug Administration for fumbling its oversight…
Opinion: Covid-19 has exposed cracks in the global medicines supply chain. We need to fix them
The Covid-19 pandemic has upended the normal ways of doing everything from going to school…
KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Demonstrated Clinically Meaningful Tumor Response Rates in Unresectable Hepatocellular Carcinoma and Advanced Renal Cell Carcinoma
Dateline City: KENILWORTH, N.J. & WOODCLIFF LAKE, N.J. Analyses from KEYTRUDA Plus LENVIMA Trials to…
Merck’s KEYTRUDA® (pembrolizumab) Superior to Standard of Care Chemotherapy in Patients with MSI-H Colorectal Cancer
Dateline City: KENILWORTH, N.J. KEYTRUDA Monotherapy Significantly Reduced Risk of Disease Progression or Death by…
Opinion: Beating Covid-19 will change how new therapies are developed
The global Covid-19 pandemic has left families and communities around the globe grieving for lost…
Merck Announces Third-Quarter 2020 Dividend
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…
Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801
Dateline City: KENILWORTH, N.J. & MIAMI Clinical Studies of EIDD-2801 for the Treatment of Patients…
.jpg)
IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
Dateline City: KENILWORTH, N.J. & NEW YORK New Collaboration to Leverage Complementary Expertise and Capabilities…
Merck to Acquire Themis
Dateline City: KENILWORTH, N.J. Merck to Apply its Industry-Leading Vaccine Development Capabilities to SARS-CoV-2 Vaccine…
Merck to Announce Multiple Scientific Efforts to Combat COVID-19
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…
STAT Plus: Experts push for a ‘seal of approval’ to improve the quality of medicines
Should there be a Good Housekeeping ‘seal of approval’ for prescription medicines? In a new…
Opinion: Biopharma companies are spreading misinformation — and taking advantage of it
As Covid-19 upends the world, people are putting their faith in the biopharma industry to…
STAT Plus: Pharma panics as Washington pushes to bring drug manufacturing back to the U.S.
WASHINGTON — As the coronavirus pandemic disrupts global supply chains, lawmakers are increasingly calling on…
First generic version of Gilead’s remdesivir will be sold by a Bangladesh drug maker
A drug maker in Bangladesh has become the first company to sell a generic version…
STAT Plus: In a tale of two Mercks, the German company wins a court battle over its U.S. rival
In a setback for Merck (MRK), a court in London ruled that the big drug…
STAT Plus: After years of manufacturing problems, Akorn files for bankruptcy protection
After mounting financial and manufacturing woes, Akorn (AKRX) has filed for bankruptcy protection, a humbling…
LYNPARZA® (olaparib) Approved by FDA for Treatment of HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer That Has Progressed Following Prior Treatment with Enzalutamide or Abiraterone
Dateline City: KENILWORTH, N.J. Only PARP Inhibitor to Improve Overall Survival vs. Enzalutamide or Abiraterone…
Opinion: Life with lupus: Trump’s hydroxychloroquine hype puts my treatment — and himself — at risk
President Trump’s revelation this week that he’s taking hydroxychloroquine to ward off Covid-19 sent shivers…
Infectious Disease Connect and ILÚM Health Solutions Combine to Advance Precision Treatment of Infectious Diseases and Antimicrobial Stewardship
Dateline City: KENILWORTH, N.J. & PITTSBURGH Agreement Includes Strategic Investments from UPMC Enterprises and Merck…
Merck Announces Appointment of Organon & Co. Chief Financial Officer and Chief Information Officer
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…
Utah went all-in on an unproven Covid-19 treatment, then scrambled to course-correct
Even before President Trump started plugging chloroquine and hydroxychloroquine as Covid-19 treatments, enthusiasm for the…
Merck to Present at the UBS Virtual Global Healthcare Conference
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…